Little is known about the innate immune response to severe acute respiratory syndrome (SARS) coronavirus (CoV) infection. Mannose-binding lectin (MBL), a key molecule in innate immunity, functions as an anteantibody before the specific antibody response. Here, we describe a case-control study that included 569 patients with SARS and 1188 control subjects and used in vitro assays to investigate the role that MBL plays in SARS-CoV infection. The distribution of MBL gene polymorphisms was significantly different between patients with SARS and control subjects, with a higher frequency of haplotypes associated with low or deficient serum levels of MBL in patients with SARS than in control subjects. Serum levels of MBL were also significantly lower in patients with SARS than in control subjects. There was, however, no association between MBL genotypes, which are associated with low or deficient serum levels of MBL, and mortality related to SARS. MBL could bind SARS-CoV in a dose-and calcium-dependent and mannan-inhibitable fashion in vitro, suggesting that binding is through the carbohydrate recognition domains of MBL. Furthermore, deposition of complement C4 on SARSCoV was enhanced by MBL. Inhibition of the infectivity of SARS-CoV by MBL in fetal rhesus kidney cells (FRhK-4) was also observed. These results suggest that MBL contributes to the first-line host defense against SARS-CoV and that MBL deficiency is a susceptibility factor for acquisition of SARS.Severe acute respiratory syndrome (SARS), a newly emerged infectious disease of humans, has affected 125 countries, with 8098 cases and 774 deaths reported to the World Health Organization (WHO) during the first half of 2003 [1]. The most affected locations were mainland China, Hong Kong, Taiwan, Singapore, and To-

Road transport consumes significant quantities of fossil fuel and accounts for a significant proportion of CO2 and pollutant emissions worldwide. The driver is a major and often overlooked factor that determines vehicle performance. Eco-driving is a relatively low-cost and immediate measure to reduce fuel consumption and emissions significantly. This paper reviews the major factors, research methods and implementation of eco-driving technology. The major factors of eco-driving are acceleration/deceleration, driving speed, route choice and idling. Eco-driving training programs and in-vehicle feedback devices are commonly used to implement eco-driving skills. After training or using in-vehicle devices, immediate and significant reductions in fuel consumption and CO2 emissions have been observed with slightly increased travel time. However, the impacts of both methods attenuate over time due to the ingrained driving habits developed over the years. These findings imply the necessity of developing quantitative eco-driving patterns that could be integrated into vehicle hardware so as to generate more constant and uniform improvements, as well as developing more effective and lasting training programs and in-vehicle devices. Current eco-driving studies mainly focus on the fuel savings and CO2 reduction of individual vehicles, but ignore the pollutant emissions and the impacts at network levels. Finally, the challenges and future research directions of eco-driving technology are elaborated.

Background: Cytokines play important roles in antiviral action. We examined whether polymorphisms of IFN-γ,TNF-α and IL-10 affect the susceptibility to and outcome of severe acute respiratory syndrome (SARS).

Highlights Two pairs of HEVs and ICE vehicles were tested in a novel convoy mode using PEMS. Both HEVs and ICE vehicles had higher RDE fuel consumption than laboratory results. HEVs saved 23%-49% fuel relative to their ICE counterparts in real-driving. HEVs showed no reduction in HC and consistently higher CO compared to ICE vehicles.